Additional file 1 of Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa

Authors :: Ndayisaba, Gilles
Yeka, Adoke
Asante, Kwaku Poku
Grobusch, Martin P.
Karita, Etienne
Mugerwa, Henry
Asiimwe, Stephen
Oduro, Abraham
Fofana, Bakary
Doumbia, Seydou
Jain, Jay Prakash
Barsainya, Sarita
Kullak-Ublick, Gerd A.
Su, Guoqin
Schmitt, Esther K.
Csermak, Katalin
Gandhi, Preetam
Hughes, David
Publisher :: figshare
Abstract: Additional file 1. Supplement Hepatic safety and tolerability of cipargamin (KAE609).

Tools